ALERT: This system is being upgraded on Tuesday December 12. It will not be available
for use for several hours that day while the upgrade is in progress. Deposits to DukeSpace
will be disabled on Monday December 11, so no new items are to be added to the repository
while the upgrade is in progress. Everything should be back to normal by the end of
day, December 12.
Browsing by Author "Krasuski, Richard A"
Now showing items 1-20 of 62
-
A Multifaceted Approach to Pulmonary Hypertension in Adults With Congenital Heart Disease.
(Progress in cardiovascular diseases, 2018-09)Advances in the management of congenital heart disease (CHD) in children have resulted in growing numbers of adults with CHD. Pulmonary arterial hypertension related to CHD (PAH-CHD) is a common complication, affecting up ... -
Adult Congenital Heart Disease Care Provision: the Need for a Jack/Jackie of All Trades.
(Progress in cardiovascular diseases, 2018-09) -
Association Between Obesity and Cardiovascular Outcomes: A Systematic Review and Meta-analysis of Mendelian Randomization Studies.
(JAMA network open, 2018-11-02)Importance:Although dyslipidemia has been consistently shown to be associated with atherogenesis, an association between obesity and cardiovascular disease outcomes remains controversial. Mendelian randomization can minimize ... -
Association of anemia and long-term survival in patients with pulmonary hypertension.
(Int J Cardiol, 2011-08-04)BACKGROUND: Anemia is a marker of worsened clinical outcome in patients with heart failure from left ventricular dysfunction. Pulmonary hypertension often results in right ventricular dysfunction. Accordingly we sought to ... -
Atheromatous disease of the aorta and perioperative stroke.
(J Thorac Cardiovasc Surg, 2017-09-14) -
Best Practice Advisories Should Not Replace Good Clinical Acumen.
(Am J Med, 2016-09-15) -
Characteristics of pediatric pulmonary hypertension trials registered on ClinicalTrials.gov.
(Pulm Circ, 2017-04)The investigation of pediatric pulmonary hypertension (PH) drugs has been identified as a high priority by the United States National Institutes of Health (NIH). Studying pediatric PH is challenging due to the rare ... -
Comparison of long-term postoperative sequelae in patients with tetralogy of Fallot versus isolated pulmonic stenosis.
(Am J Cardiol, 2014-07-15)Patients with tetralogy of Fallot (TOF) after complete repair and pulmonic stenosis (PS) after surgical valvotomy often develop significant pulmonic regurgitation (PR) that eventually requires valve replacement. Although ... -
Conflicts of Interest and Outcomes of Cardiovascular Trials.
(Am J Cardiol, 2016-03-01)Conflicts of interests have long been recognized as potential sources of influence in the conduct and reporting of clinical trials. This controversy was again rekindled after the publication of the latest statin guidelines ... -
Congenital heart disease and pulmonary hypertension.
(Heart Fail Clin, 2012-07)Many patients with congenital heart disease and systemic-to-pulmonary shunts develop pulmonary arterial hypertension (PAH), particularly if the cardiac defect is left unrepaired. A persistent increase in pulmonary blood ... -
Congenital Heart Disease Epidemiology in the United States: Blindly Feeling for the Charging Elephant.
(Circulation, 2016-07-12) -
Contributors to and impact of residual shunting after device closure of atrial septal defects.
(Am Heart J, 2016-07)BACKGROUND: The prevalence of residual shunt in patients after device closure of atrial septal defect and its impact on long-term outcome has not been previously defined. METHODS: From a prospective, single-institution registry ... -
Coronary Disease and Modifying Cardiovascular Risk in Adult Congenital Heart Disease Patients: Should General Guidelines Apply?
(Progress in cardiovascular diseases, 2018-09)There are >1.4 million adult congenital heart disease (CHD; ACHD) patients living in the United States. Coronary artery disease (CAD) is at least as prevalent in ACHD patients as in the general population and has become ... -
Deep thoughts on lipids and cognition.
(Curr Opin Lipidol, 2017-06) -
Downstream coronary effects of drug-eluting stents.
(Am Heart J, 2011-10)BACKGROUND: Antiproliferative agents used in drug-eluting stents (DES) attenuate atherosclerosis, yet DES implantation has been linked to endothelial dysfunction. The downstream effects of DES on new lesion formation have ... -
Effect of obesity on B-type natriuretic peptide levels in patients with pulmonary arterial hypertension.
(Am J Cardiol, 2012-09-15)Brain natriuretic peptide (BNP) levels are lower in obese patients with left ventricular failure than in their comparably ill, leaner counterparts. The effect of obesity on BNP in patients with pulmonary arterial hypertension ... -
Effect of Patent Foramen Ovale in Patients With Pulmonary Hypertension.
(The American journal of cardiology, 2018-08)Septostomy reduces right ventricular (RV) workload at the expense of hypoxemia in patients with advanced pulmonary hypertension (PH). A patent foramen ovale (PFO) may serve as a "natural" septostomy, but the incidence and ... -
Embolization of patent foramen ovale closure devices: incidence, role of imaging in identification, potential causes, and management.
(Tex Heart Inst J, 2013)Transcatheter patent foramen ovale (PFO) closure is an alternative to antiplatelet or anticoagulative therapy in patients with cryptogenic stroke, and it is associated with a small incidence of periprocedural sequelae. Because ... -
Extra-cardiac manifestations of adult congenital heart disease.
(Trends Cardiovasc Med, 2016-10)Advancement in correction or palliation of congenital cardiac lesions has greatly improved the lifespan of congenital heart disease patients, resulting in a rapidly growing adult congenital heart disease (ACHD) population. ... -
Health insurance and racial disparities in pulmonary hypertension outcomes.
(Am J Manag Care, 2017-08)OBJECTIVES: Pulmonary hypertension portends a poorer prognosis for blacks versus white populations, but the underlying reasons are poorly understood. We investigated associations of disease characteristics, insurance status, ...
